621 related articles for article (PubMed ID: 18367383)
1. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Sarifakioglu E; Seçkin D; Demirbilek M; Can F
Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
5. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
Bhatia VK; Sharma PC
Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
[TBL] [Abstract][Full Text] [Related]
6. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
Hazen KC
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S37-41. PubMed ID: 9594935
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
Garcia-Effron G; Gomez-Lopez A; Mellado E; Monzon A; Rodriguez-Tudela JL; Cuenca-Estrella M
J Antimicrob Chemother; 2004 Jun; 53(6):1086-9. PubMed ID: 15102749
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Gupta AK; Kohli Y; Batra R
Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
[TBL] [Abstract][Full Text] [Related]
9. [Is amphotericin B active against dermatophytes and Scopulariopsis brevicaulis?].
Carrillo-Muñoz AJ; Santos P; del Valle O; Casals JB; Quindós G
Rev Esp Quimioter; 2004 Sep; 17(3):244-9. PubMed ID: 15619653
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis.
Karaarslan A; Arikan S; Ozcan M; Ozcan KM
Mycoses; 2004 Aug; 47(7):284-7. PubMed ID: 15310330
[TBL] [Abstract][Full Text] [Related]
15. Determination of susceptibility/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method.
Barros ME; Hamdan JS
Can J Microbiol; 2005 Nov; 51(11):983-7. PubMed ID: 16333338
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Li L; Wang Z; Li R; Luo S; Sun X
Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A
Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the antimicrobial susceptibility of fungi responsible for onychomycosis in Spain.
Zalacain A; Obrador C; Martinez JP; Viñas M; Vinuesa T
Med Mycol; 2011 Jul; 49(5):495-9. PubMed ID: 21142899
[TBL] [Abstract][Full Text] [Related]
20. Activity of terbinafine against serious fungal pathogens.
Ryder NS
Mycoses; 1999; 42 Suppl 2():115-9. PubMed ID: 10865917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]